Drugs/Recall·openFDA/drug

Guardian Drug Co. Inc. — Class II: CAREone, EXTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 750 mg, 96 chewable Tablets, Di

MediumPublished Jun 10, 2026· AI-analyzed Jun 15, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Guardian Drug Co. Inc. has initiated a Class II recall for CAREone Extra Strength Calcium Antacid chewable tablets due to the presence of small metallic particles.

Who it affects

This affects Guardian Drug Co. Inc. as the manufacturer, Foodhold U.S.A, LLC as the distributor, and quality/manufacturing professionals involved in OTC solid oral dosage form production.

Why it matters

The discovery of metallic particles suggests a potential failure in physical contaminant controls or equipment integrity during the manufacturing process. A Class II designation indicates that exposure may cause temporary or medically reversible adverse health consequences, necessitating a review of batch records and physical filtration/detection systems.

Practical takeaway

QA teams should review foreign material exclusion programs and maintenance logs for tablet presses or granulation equipment. Regulatory affairs should monitor the status of this ongoing recall to determine if additional lots or related private-label products are affected.

FDA source material

Class II. Reason: Presence of foreign substance: small metallic particles in chewable tablets.. Product: CAREone, EXTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 750 mg, 96 chewable Tablets, Distributed by: FOODHOLD U.S.A, LLC, LANDOVER, MD 20785, NDC 72476-127-80.. Firm: Guardian Drug Co. Inc. (Dayton NJ United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.